[HTML] frontiersin.org

[HTML][HTML] Activation of Nrf2 signaling: A key molecular mechanism of protection against cardiovascular diseases by natural products

X Wu, J Wei, Y Yi, Q Gong, J Gao - Frontiers in Pharmacology, 2022 - frontiersin.org
Cardiovascular diseases (CVD) are a group of cardiac and vascular disorders including
myocardial ischemia, congenital heart disease, heart failure, hypertension, atherosclerosis …
被引用次数：13 相关文章

Activation of Nrf2 signaling: A key molecular mechanism of protection against cardiovascular diseases by natural products

X Wu, J Wei, Y Yi, Q Gong… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Cardiovascular diseases (CVD) are a group of cardiac and vascular disorders including
myocardial ischemia, congenital heart disease, heart failure, hypertension, atherosclerosis …

Activation of Nrf2 signaling: A key molecular mechanism of protection against cardiovascular diseases by natural products

X Wu, J Wei, Y Yi, Q Gong, J Gao - Frontiers in Pharmacology, 2022 - europepmc.org
Cardiovascular diseases (CVD) are a group of cardiac and vascular disorders including
myocardial ischemia, congenital heart disease, heart failure, hypertension, atherosclerosis …
[HTML] nih.gov

[HTML][HTML] Activation of Nrf2 signaling: A key molecular mechanism of protection against cardiovascular diseases by natural products

X Wu, J Wei, Y Yi, Q Gong, J Gao - Frontiers in Pharmacology, 2022 - ncbi.nlm.nih.gov
Cardiovascular diseases (CVD) are a group of cardiac and vascular disorders including
myocardial ischemia, congenital heart disease, heart failure, hypertension, atherosclerosis …

Activation of Nrf2 signaling: A key molecular mechanism of protection against cardiovascular diseases by natural products.

X Wu, J Wei, Y Yi, Q Gong, J Gao - Frontiers in Pharmacology, 2022 - europepmc.org
Cardiovascular diseases (CVD) are a group of cardiac and vascular disorders including
myocardial ischemia, congenital heart disease, heart failure, hypertension, atherosclerosis …